Lawrence H. Biegelsen

Research Analyst at Wells Fargo & Company/mn

Lawrence H. Biegelsen is Managing Director and Senior Analyst specializing in medical technology and healthcare equity research at Wells Fargo Securities, with over 30 years of industry experience and more than 15 years covering the medical device sector. He covers major companies such as Medtronic, Johnson & Johnson, Cooper Companies, Tandem Diabetes Care, Penumbra, and Inari Medical, and is recognized for a strong track record, achieving a 53% success rate and an average return of 4.4% per rating on TipRanks, with individual calls like a +266.5% gain on Shockwave Medical. Biegelsen began his equity research career at Prudential Securities in 2005 before joining Wells Fargo in 2010, and previously held leadership roles at Merck and Pfizer Japan. He holds an MBA in finance from New York University, a BA from Tulane University, and maintains active FINRA registration as a broker.